The 13-year long-term follow-up on the effectiveness and immunogenicity of the quadrivalent human papillomavirus vaccine in Chinese females vaccinated at 20-45 years of age

• Principais autores: Tianmeng Wen (Autor), Xiaoqian Xu (Autor), Chenghao Pan (Autor), Shangying Hu (Autor), Huan Zhao (Autor), Xun Zhang (Autor), Youlin Qiao (Autor), Fanghui Zhao (Autor)
• Formato: Livro
• Publicado em: Taylor & Francis Group, 2024-12-01T00:00:00Z.
• Assuntos: article
• Acesso em linha: Connect to this object online.

The quadrivalent human papillomavirus (qHPV) vaccine demonstrated high efficacy against vaccine-type-related precancers in Chinese females through a 6.6-year double-blind, randomized control trial (V501-041, NCT00834106). We present results for its long-term follow-up (LTFU) phase, evaluating vaccin...